Condition
Clonal Hematopoiesis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Clonal Hematopoiesis clinical trials that are recruiting, at sites in 4 countries (most in United States (5), Canada (1), Hong Kong (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Clonal Hematopoiesis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| High-Fiber Plant-Based Diet in People with Clonal Hematopoiesis | — | Basking Ridge, New Jersey and 6 other locations | Recruiting | May 15, 2026 |
| Clonal haematopoiesis assessment and long-term monitoring for prevention and care | — | Canberra, Australian Capital Territory | Recruiting | Dec 31, 2025 |
| Registry and biorepository for clonal hematopoiesis and its effects on health | — | Nashville, Tennessee | Recruiting | Nov 22, 2024 |
| Investigating blood cancer risks in patients with ovarian and other solid tumors | — | Seattle, Washington | Recruiting | Mar 6, 2024 |
| Examining blood cell growth patterns and heart health in Hodgkin lymphoma survivors | — | Mobile, Alabama and 35 other locations | Recruiting | Jan 30, 2023 |
| Impact of donor gene mutations on outcomes after stem cell transplantation | — | Hong Kong | Recruiting | Dec 30, 2020 |
| Understanding Li-Fraumeni Syndrome and TP53 Variants | — | Boston, Massachusetts and 2 other locations | Recruiting | Sep 9, 2020 |
All recruiting trials (7)
-
High-Fiber Plant-Based Diet in People with Clonal Hematopoiesis
This study tests whether a high-fiber plant-based diet can improve quality of life for adults with clonal hematopoiesis.
-
Clonal haematopoiesis assessment and long-term monitoring for prevention and care
This project will follow people aged 55 and older who have clonal haematopoiesis or unexplained low blood counts to see how their blood changes over time and whether they develop heart disease or blood cancers.
-
Registry and biorepository for clonal hematopoiesis and its effects on health
This study is trying to understand how clonal hematopoiesis affects health, especially heart risks and blood cancers, by collecting information and samples from patients with this condition or those at higher risk.
-
Investigating blood cancer risks in patients with ovarian and other solid tumors
This study is trying to see if certain cancer treatments for ovarian and other solid tumors can increase the risk of blood cancers in patients.
-
Examining blood cell growth patterns and heart health in Hodgkin lymphoma survivors
This study is trying to see if certain blood cell changes in people who survived Hodgkin lymphoma can help us understand their heart health better and identify those at risk for heart problems.
-
Impact of donor gene mutations on outcomes after stem cell transplantation
This study is testing how gene mutations in stem cell donors affect the health and recovery of patients receiving their transplants.
-
Understanding Li-Fraumeni Syndrome and TP53 Variants
This study is trying to understand cancer risks in people with Li-Fraumeni Syndrome or TP53 gene changes to help improve prevention and treatment options.
Related topics
Quick answers
How many Clonal Hematopoiesis clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (5 trials), Canada (1 trial), Hong Kong (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.